Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BuCE vs BuME Conditioning for ASCT in Non-Hodgkin's Lymphoma
NCT03794167Phase 2Completed
- Sponsor
- Soonchunhyang University Hospital
- Start
- Jun 2012
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cyclophosphamide in non-Hodgkin lymphoma (NHL) (2 arms), sponsored by Soonchunhyang University Hospital. Primary endpoint: Progression-Free Survival at 2 years. Started Jun 2012; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT03794167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03794167.